IDENTIFICATION OF FUNCTIONAL SNPs OF MDR1 GENE AMONG NEPHROTIC SYNDROME CHILDREN IN SOUTH INDIA
Objective: This study was conducted to determine the frequency of C3435T and G2677T/C single nucleotide polymorphisms of multi drug resistance
gene -1 (MDR1) in nephrotic syndrome (NS) children in relation to healthy subjects. The role and association of these SNPs were also determined,
whether response and/or resistance to steroid treatment in children with NS in south India.
Methods: Genomic DNA was isolated from 371 blood samples collected from children with NS and controls. Among 173 cases, categorized into
steroid-resistant NS (SRNS) were 90 and steroid-sensitive NS (SSNS) were 83 and 198 blood samples were included as controls. All samples were
subjected to DNA extraction, and polymerase chain reaction followed by restriction fragment length polymorphism for identification of C3435T and
G2677T/C genomic variations.
Results: The frequencies of MDR-1 C3435T, CT, TT, and CC genotypes and SNP G2677T/C GG and G allele genotypes were observed in this study group.
In SRNS, children showed significantly higher frequencies of MDR-1 C3435T, CT, TT, and TT+CC genotypes were observed than SRNS and controls.
The allele frequencies of SRNS children showed CC - 4%, CT - 32% and TT - 12% and in SSNS children, CC - 10.98%, CT - 27.2% and TT - 13.9% were
observed. Furthermore, increased frequencies of MDR-1 C3435T CT, TT, TT+CC genotypes, or T allele were observed in children aged <9 years old.
There were no different genotype and allele frequency observed in G2677T/C genotypes NS children and controls.
Conclusion: Based on these data, we are suggesting that MDR-1 C3435T gene polymorphisms are risk factors of increased susceptibility, earlier
onset of NS as well as leads to steroid resistance. Whereas SNP G2677T/C gene polymorphisms do not have significant role observed in this study
Keywords: Nephrotic syndrome, Steroid-sensitive nephrotic syndrome, Steroid-resistant nephrotic syndrome, Multidrug resistance gene-1,
Polymerase chain reaction followed by restriction fragment length polymorphism.
2. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981;98(4):561-4.
3. Niaudet P. Steroid-resistant idiopathic nephrotic syndrome in children. In: Avner ED, Harmon WE, Niaudet P, editors. Pediatric Nephrology. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
4. Klimecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein
expression and function in circulating blood cells from normal
volunteers. Blood 1994;83(9):2451-8.
5. Chanchlani R, Parekh RS. Ethnic differences in childhood nephrotic
syndrome. Front Pediatr 2016;4:39.
6. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette
(ABC) transporter superfamily. Genome Res 2001;11(7):1156-66.
7. Gottesman MM, Pastan I. Biochemistry of multidrug resistance
mediated by the multidrug transporter. Annu Rev Biochem
8. Lespine A, MÃ©nez C, Bourguinat C, Prichard RK. P-glycoproteins
and other multidrug resistance transporters in the pharmacology of
anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance. Int J Parasitol Drugs Drug Resist 2011;2:58-75.
9. Lin JH. Drug-drug interaction mediated by inhibition and induction of
P-glycoprotein. Adv Drug Deliv Rev 2003;55(1):53-81.
10. Salama NN, Yang Z, Bui T, Ho RJ. MDR1 haplotypes significantly
minimize intracellular uptake and transcellular P-gp substrate transport
in recombinant LLC-PK1 cells. J Pharm Sci 2006;95(10):2293-308.
11. Li YH, Wang YH, Li Y, Yang L. MDR1 gene polymorphisms and
clinical relevance. Acta Genet Sin 2006;33(2):93-104.
12. Umamaheswaran G, Krishna Kumar D, Kayathiri D, Rajan S, ShewadeDG, Dkhar SA, et al. Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population. Mol Biol Rep 2012;39(5):6343-51.
13. Youssef DM, Attia TA, El-Shal AS, Abduelometty FA. Multi-drug
resistance-1 gene polymorphisms in nephrotic syndrome: Impact on
susceptibility and response to steroids. Gene 2013;530(2):201-7.
14. Emeneau MB. India as a lingustic area. Language 1956;32(1):3-16.
15. Anochie I, Eke F, Okpere A. Childhood nephrotic syndrome: Change in pattern and response to steroids. J Natl Med Assoc2006;98(12):1977-81.
16. Coppo R. Non-steroidal and non-cytotoxic therapies for nephrotic
syndrome. Nephrol Dial Transplant 2008;23(6):1793-6.
17. Moustafa BH, Tolba OA. Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: A single center experience. Electron Physician 2016;8(2):2039-47.
18. PeÃ±a A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L,
et al. Steroid-resistant nephrotic syndrome: Long-term evolution after
sequential therapy. Pediatr Nephrol 2007;22(11):1875-80.
19. Cizmarikova M, Podracka L, Klimcakova L, Habalova V, Boor A,
Mojzis J, et al. MDR1 polymorphisms and idiopathic nephrotic
syndrome in Slovak children: Preliminary results. Med Sci Monit
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.